Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT

BACKGROUND: Autologous haematopoietic stem cell transplantation (AHSCT) is a highly effective treatment for multiple sclerosis (MS). The impact of previous long-lasting disease-modifying treatments (DMT) for safety and efficacy of AHSCT is unknown. OBJECTIVE: To explore whether previous DMTs with lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kvistad, Silje Agnethe Stokke, Burman, Joachim, Lehmann, Anne Kristine, Tolf, Andreas, Zjukovskaja, Christina, Melve, Guro Kristin, Bø, Lars, Torkildsen, Øivind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Multiple Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304086/
https://www.ncbi.nlm.nih.gov/pubmed/35508373
http://dx.doi.org/10.1136/jnnp-2022-328797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304086/
https://www.ncbi.nlm.nih.gov/pubmed/35508373
http://dx.doi.org/10.1136/jnnp-2022-328797

Ejemplares similares